CAPRA BENEFITS

The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is an organization dedicated to providing its members with opportunities to enhance their professional development and maximize career opportunities. Whether you are a student, an entry-level associate or an experienced executive, a membership with CAPRA is a must.

We foster learning, networking and professional excellence of our members. We will build and strengthen relationships with governmental agencies, scientific experts and industry educators in order to create an affordable, professionally fulfilling and academically enriching environment for our members.

Learn More

WHY JOIN CAPRA AS A STUDENT?

Introduction to Regulatory Affairs and the Regulatory Affairs Profession

LEARN MORE

CONSULTANTS

A listing on the CAPRA website is available to consulting companies whose primary focus is Regulatory Affairs, Clinical Research, Quality Control or Compliance (GCP, GLP, GMP) for pharmaceuticals, biologics, veterinary drugs, medical devices, cosmetics, over-the-counter products, or natural health products.

NEWMARKET, Ontario McCarthy Consultant Services, Inc. 2018-01-30
Mississauga, Ontario RegCon Solutions Canada 2018-02-07
Kitchener, Ontario NaturalSci Regulatory Consulting Corp 2018-01-30
Toronto, Ontario AAPS-Academy of Applied Pharmaceutical Sciences 2018-01-30
Vancouver, British Columbia Worldwide BioMedEx Inc. 2018-01-30

ADVERTISE WITH CAPRA

Reach CAPRA members through the NOC (News of Course), or place an employment ad in our listings.

LEARN MORE

EMPLOYMENT LISTINGS

Available to CAPRA Members

Planning to place an employment advertisement through CAPRA/ACRP? Looking for a new career opportunity? If so, you have come to the right place! CAPRA now has over 900 members in the regulatory affairs field!

Job Seekers: Scroll through our most recent postings, your dream job maybe at your fingers tips!

Employers: Regulatory professionals are difficult to find. Win the competition for talent, by advertising in CAPRA. Our email employment notice service brings you access to hundreds of top class, experienced professionals. One of them may be just whom you are looking for!

VIEW OPPORTUNITIES

CAPRA BLOG

The Australia Canada Singapore Switzerland (ACSS) Consortium

The Australia Canada Singapore Switzerland (ACSS) Consortium

The creation of the Consortium allows these regulatory agencies to discuss ways to enhance and even align the regulatory reviews of certain drug products.

Administrative Processing of Submissions and Applications: Human or Disinfectant Drugs

Administrative Processing of Submissions and Applications: Human or Disinfectant Drugs

On March 1, 2018, the guidance document “Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs” (the “Guidance Document”) came into effect. The Guidance Document applies to drug submissions and applications involving biologics, radiopharmaceuticals, human pharmaceuticals and disinfectants regulated under the Food and Drugs Act. The coming into effect of the Guidance Document will be April 1, 2019 in respect of disinfectant drugs.

CADTH Revisions to the Biosimilar Review Process and Resubmission

CADTH Revisions to the Biosimilar Review Process and Resubmission

In late 2017, the Canadian Agency for Drugs and Technologies in Health (“CADTH”) announced an open consultation on proposed changes to the Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (“pCODR”) for the review of biosimilar drug products. The consultation also addressed the resubmission eligibility criteria for drugs subject to CDR or pCODR along with various administrative changes. On February 2018, CADTH announced new operational changes resulting from the consultation and to enhance the drug review process.